Poop pills take on superbugs in new clinical trial

NCT ID NCT07265817

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether taking capsules containing fecal matter from healthy donors can eliminate drug-resistant bacteria living in the gut. Sixty patients with carbapenem-resistant Enterobacteriaceae will receive either the real transplant or a placebo for three days. The goal is to see if the treatment can turn their lab tests negative for the superbug.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

fecal microbiota transplant capsules

What this could lead to

If it works, this could offer a way to remove dangerous drug-resistant bacteria from the gut without antibiotics, reducing infection risk.

What could go wrong

This is a small, early-stage trial with only 60 participants. The treatment may not work for everyone, and there is a small risk of infection or side effects from the transplant.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARBAPENEM-RESISTANT ENTEROBACTERIACEAE COLONIZATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.